The Stack: How IDEXX Built a Vertical Monopoly Over Veterinary Imaging — From the X-Ray Machine to the Radiologist’s Report

Most veterinary practices think of IDEXX as a diagnostics company — the one that runs their blood panels and sells their in-clinic analyzers. That framing is exactly what IDEXX wants. The fuller picture is of a company that has spent thirty years quietly assembling every layer of the veterinary imaging stack: the hardware, the software, the image archive, the reading service, and the talent pipeline that feeds it. Understanding that structure is essential for any practice that wants to know what it has already given up — and what it still controls.

Foundation: A Diagnostics Company That Learned to See

IDEXX Laboratories was founded in 1983 in Westbrook, Maine by David E. Shaw, initially targeting diagnostic tests for the poultry industry. The pivot to companion animal medicine proved far more lucrative. The 1988 launch of the VetTest Chemistry Analyzer established IDEXX’s foundational business model: place proprietary instruments into veterinary practices, then lock those practices into a recurring consumables relationship that generates margin for decades. By 2008, annual revenues had crossed $1 billion. By 2024, the company reported full-year revenue of $3.9 billion — with the Companion Animal Group accounting for roughly 92% of the total.

For most of its first two decades, IDEXX’s imaging ambitions were limited. Digital radiography was expensive, DICOM standards were still being adopted in veterinary medicine, and the teleradiology market barely existed. But by the mid-2000s, conditions were changing rapidly. Broadband internet made remote image transmission practical. DICOM had been formalized as the veterinary standard. And a small but growing ecosystem of independent teleradiology companies had begun proving that remote specialist reads were commercially viable.

IDEXX watched, and then it moved.

The Acquisitions: Building the Stack One Layer at a Time

What follows is not a summary of a single strategic decision. It is a chronicle of layered acquisitions, each targeting a different piece of the imaging workflow, executed over roughly fifteen years. The result is a vertically integrated system that most practices encounter only one layer at a time — which is precisely why the full picture is so rarely discussed.

The Stack: What IDEXX Controls Today

The individual acquisitions are easier to understand when mapped to the layers they occupy. A veterinary imaging encounter — from the moment a patient walks in through the moment the referring veterinarian reads a specialist’s report — passes through each of these layers. IDEXX has a product at every one of them.

The Mechanism of Lock-In: Why Integration Is Not Neutral

IDEXX markets its integrated stack as a workflow benefit — and it is one, genuinely. A practice running IDEXX hardware, IDEXX Web PACS, and an IDEXX-integrated PIMS experiences a remarkably seamless workflow. Image ordering is automatic. Submitting a case to IDEXX Telemedicine Consultants requires a single click from within the PACS. Reports return directly into the patient record. The AI features work without any additional configuration.

None of that is accidental. It is the product of deliberate architectural choices designed to make the integrated IDEXX workflow maximally convenient — and to make alternatives maximally inconvenient.

Consider what happens when a practice running IDEXX hardware and Web PACS wants to send a case to a different teleradiology service. Technically, DICOM is an open standard, and images should be transferable to any DICOM-compatible system. In practice, the IDEXX PACS stores images on IDEXX’s servers. Retrieving those images for submission to a competitor requires a manual export process. The automatic case-submission workflow — one click from PACS to IDEXX Telemedicine Consultants — has no equivalent for non-IDEXX readers. The IDEXX VetMedStat portal notes explicitly that “IDEXX PACS users — if you submit cases using IDEXX PACS or Web PACS, you can still submit cases via PACS as usual.” The friction reduction is reserved for the IDEXX-to-IDEXX pathway.

The IDEXX Web PACS product page puts the integration pitch succinctly: it allows practices to “communicate with IDEXX Telemedicine Consultants to get trusted insights and reports” — not with any radiologist of the practice’s choosing, but with IDEXX’s radiologists specifically. The architecture routes toward IDEXX by default. Routing elsewhere requires active effort.

What the Northwest Veterinary Imaging Letter Reveals

In 2021, Northwest Veterinary Imaging (NWVI), a small independent teleradiology practice run by two veterinarians, Steve and Julie, posted a letter to their referring community announcing that their teleradiology practice would merge with IDEXX Telemedicine. The letter is candid in ways that corporate communications rarely are.

The reasons given were personal: a growing DICOM caseload had become unsustainable, and the radiologists running the practice wanted to spend more time with their families. But embedded in the letter is a structural admission: “recent growth in the DICOM caseload has presented a significant challenge to the practice.” The explanation for choosing IDEXX specifically: “IDEXX is a global leader in teleradiology and information technology. The radiology team includes many of the specialty’s preeminent radiologists and is well-known for its culture of collegiality and collaboration.”

The letter closes with a telling detail about the mechanics of transition: “An IDEXX representative will be contacting you during the upcoming weeks to discuss the next steps.” The referring veterinary community wasn’t asked to choose a new teleradiology provider. They were told one had been chosen for them, and that IDEXX would be in touch.

This is the pattern of consolidation in miniature. An independent teleradiology practice, facing the economics of growth and the limits of a two-person operation, finds that the only viable exit is acquisition by — or merger with — IDEXX. The referring practices that had built relationships with NWVI over years are absorbed into the IDEXX client base. The independent alternative disappears. IDEXX’s market position strengthens. No law was broken. No antitrust threshold was triggered. The market simply got smaller.

The Talent Pipeline: Training Tomorrow’s Radiologists Inside the System

One dimension of IDEXX’s vertical integration that receives almost no public attention is its relationship to the academic pipeline that produces board-certified veterinary radiologists.

VDIC, the company IDEXX acquired in 2009, ran a formal ACVR-affiliated radiology residency in partnership with Oregon State University and Washington State University. The residents who trained at VDIC became diplomates through the standard ACVR credentialing process, but they did so inside a commercial teleradiology company’s infrastructure. When IDEXX acquired VDIC, it inherited those institutional relationships. Dr. Barksdale, for instance, began her radiology residency at VDIC in 2008 and became, when IDEXX acquired VDIC in 2009, the first radiology resident to complete their training under the IDEXX banner.

This is a subtler form of vertical integration than equipment or software. The supply of board-certified veterinary radiologists is genuinely constrained — there are not nearly enough ACVR diplomates to staff all the specialty practices and teleradiology services the profession needs. A company that shapes the residency environment in which new radiologists are trained shapes those radiologists’ professional habits, institutional loyalties, and career trajectories. A new diplomate who completed their residency reading cases through IDEXX’s PACS, submitting through IDEXX’s portal, and working alongside IDEXX Telemedicine Consultants is not a neutral market participant.

Mars/Antech has pursued a parallel strategy through its Academic Cooperative program and its sponsored residencies at Cornell — as documented in a companion article on this site. IDEXX’s approach is older and less explicitly branded, but structurally similar: influence the pipeline, shape the talent, and benefit from the institutional allegiances that form during training.

The Revenue Picture: Why This Matters to IDEXX Financially

IDEXX reported full-year 2024 revenue of $3.9 billion, up 6% from 2023. Its veterinary software, services and diagnostic imaging systems segment — the bucket that includes Web PACS, PIMS products, and telemedicine consulting — grew 13% in the fourth quarter of 2024, with 7% organic growth. The company’s 2025 revenue guidance projects total revenue of $4.05–4.17 billion.

These numbers matter for understanding IDEXX’s incentives. The company’s SEC filings describe its strategy as being built on “sustained high (97%+) customer retention rate” within its key diagnostics business and “continued momentum in cloud-based software placements.” The 97%+ retention figure is not an accident — it is the financial output of an integration architecture designed to make switching costly. Every practice on IDEXX Web PACS, submitting cases to IDEXX Telemedicine Consultants through IDEXX’s one-click workflow, is a practice that has been made to depend on IDEXX for each link in the imaging chain.

IDEXX’s own investor communications acknowledge the strategic logic explicitly: the company describes its approach as offering customers “deep diagnostics insights” that “help them deliver better patient outcomes and seamless workflow for better business results,” with this “value-added partnership” setting “a strong foundation for long-term growth.” The word “partnership” is doing significant work here. In a genuine partnership, the terms are negotiated and either party can exit. The architecture IDEXX has built makes exit economically painful.

The Antitrust Question IDEXX Has Not Had to Answer

The Federal Trade Commission’s 2022 enforcement actions against JAB Consumer Partners — reviewed in a companion article on this site — established that the FTC will scrutinize horizontal consolidation in veterinary services: one company buying up competing clinics in the same geographic market. The JAB/SAGE and JAB/Ethos consent orders required clinic divestitures and imposed prospective prior approval requirements on future acquisitions.

IDEXX’s strategy presents a different kind of antitrust question — one that horizontal merger review is less well-equipped to address. IDEXX is not, in the primary sense, buying competing veterinary clinics. It is not reducing the number of practices competing for pet-owner visits in a given city. What IDEXX has done is something structurally distinct: it has vertically integrated the imaging supply chain so that independent teleradiology companies face a market in which their potential customers are systematically difficult to reach.

A practice that has adopted IDEXX hardware, IDEXX Web PACS, and an IDEXX-integrated PIMS is not a neutral buyer in the teleradiology services market. It is a buyer who has already been enrolled in a system that makes IDEXX Telemedicine Consultants the path of least resistance. Switching to an independent teleradiology service requires accepting workflow friction that the IDEXX system has been specifically designed to create.

This is the vertical integration concern that the Enforcement Gap article addresses in the abstract: antitrust law targets horizontal consolidation — buying up competitors — while anti-kickback law, had it applied to veterinary medicine, would have targeted the structural incentives that steer referrals toward affiliated providers. In the absence of veterinary anti-kickback law, and with antitrust enforcement focused on clinic-level horizontal mergers rather than supply-chain vertical integration, IDEXX’s stack has assembled largely without regulatory friction.

Whether IDEXX’s practices rise to actionable anticompetitive conduct under Section 1 or Section 2 of the Sherman Act, or under Section 5 of the FTC Act, is a question for antitrust lawyers with full access to pricing and contracting data — not a conclusion this publication is in a position to draw. What can be said is that the structure exists, that it confers substantial competitive advantages on IDEXX Telemedicine Consultants over independent teleradiology services, and that those advantages flow from architectural design rather than from quality of reads alone.

What Independent Teleradiology Looks Like Inside the IDEXX World

The practical experience of an independent teleradiology company operating in a market where many of its potential clients run IDEXX-integrated systems is not hypothetical. It is the operating reality of every non-IDEXX teleradiology service in North America today.

A general practice running IDEXX Web PACS can submit a case to IDEXX Telemedicine Consultants in a single click, with patient data pre-populated from their PIMS. Submitting the same case to an independent teleradiology service typically requires: exporting the DICOM images from the IDEXX archive (a manual process), uploading them to the independent service’s submission portal (a separate login, a separate workflow), and manually entering patient information that was already in the PIMS. The clinical outcome — a board-certified radiologist’s report — may be identical. The workflow friction is not.

In a busy practice seeing thirty or forty patients a day, workflow friction is not a minor inconvenience. It is a decisive factor. The technician who has to execute an extra five steps to route a case outside the IDEXX system — steps that don’t exist when routing to IDEXX — will default to the path of least resistance. This is not malpractice, negligence, or ethical failure. It is human behavior in a system designed to produce exactly that outcome.

The question practices rarely ask — because the integration is so seamless — is what they gave up when they adopted that seamlessness. They gave up the ability to price-shop teleradiology reads without workflow cost. They gave up the ability to send a challenging case to a radiologist with a particular subspecialty without incurring friction. And they may have given up something less tangible but more significant: the knowledge that their imaging referral decisions are made on clinical merit alone, unconstrained by architectural incentives they didn’t consciously choose.

IDEXX in Context: Mars/Antech Is Not the Same Problem

It is worth distinguishing the IDEXX structure from the Mars/Antech structure examined in a companion article on this site, because the competitive concern is different in each case.

Mars/Antech’s vertical integration in veterinary imaging runs through clinic ownership. Mars owns Banfield, VCA, BluePearl, and other clinic chains — practices that employ veterinarians and treat patients. When imaging work from a Mars-affiliated general practice is routed to Antech Imaging Services (AIS), the referring practice and the reading service are under common corporate ownership. The financial incentive to route internally is explicit, the corporate relationship is direct, and the mechanism is referral within an enterprise.

IDEXX’s integration operates differently. IDEXX does not own veterinary clinics. It does not employ the veterinarians making referral decisions. Its influence runs through the infrastructure those veterinarians use rather than through employment or corporate ownership. The IDEXX stack creates referral pathway capture through software architecture rather than through corporate hierarchy. The veterinarian making the decision is nominally independent. The system that executes the decision is not.

Both structures produce the same outcome for independent teleradiology services: systematic disadvantage in accessing their potential client base. But the legal and regulatory frameworks they implicate are distinct, and the reforms that would address each are different.

What Would Change This

The IDEXX stack is not illegal under current law, and it may not be anticompetitive in the technical antitrust sense. But the profession has tools available that it has not consistently used, and regulators have authority they have not yet applied to this specific structural pattern.

DICOM is an open standard. Every image produced on IDEXX hardware is technically a DICOM image — portable, in principle, to any DICOM-compatible archive or viewer. A practice that insists on storing its DICOM images in a PACS it controls, rather than in IDEXX’s cloud archive, preserves its ability to route those images to any reader without friction. Most practices have never made this choice — or been counseled to make it — because the default of IDEXX’s cloud archive is functionally invisible at the point of equipment adoption. Transparency about what “seamless integration” actually means in terms of data custody and referral routing would allow practices to make genuinely informed decisions.

Interoperability requirements — mandatory, open API standards for PIMS-to-PACS integration — would reduce the friction advantage that IDEXX’s proprietary stack currently enjoys. If submitting a case to any DICOM-compliant teleradiology service were as frictionless through any PIMS as submitting to IDEXX Telemedicine Consultants is through IDEXX’s own software, the competitive playing field would be substantially leveled. This is the kind of structural remedy that regulators in adjacent markets — human healthcare, financial services — have pursued with documented effect.

FTC scrutiny of the vertical structure itself — not just the horizontal clinic acquisitions that have drawn enforcement attention to date — would surface the competitive dynamics that practice-level purchasing decisions obscure. IDEXX’s market position in veterinary imaging is not merely the result of making good products. It is the result of making those products interoperate with each other in ways that make leaving the ecosystem costly. That pattern merits examination on its merits.

Conclusion: The Invisible Referral Decision

When a veterinarian at a general practice submits a radiology case through their PACS, they are making a referral decision — one of the most consequential clinical decisions a generalist makes. In human medicine, the legal framework governing that decision — the Anti-Kickback Statute, the Stark Law, the disclosure requirements that attach to financial relationships — exists precisely because Congress recognized that referral decisions can be corrupted by financial architecture, not just by individual bad intent.

In veterinary medicine, that legal framework does not exist. And in its absence, a company with sufficient resources and a long enough runway can build an architecture that shapes referral decisions at scale — not through explicit contracts or kickback payments, but through the silent gravity of a seamlessly integrated system.

IDEXX built that system. The profession is inside it. The question for every practice that has adopted IDEXX hardware, IDEXX Web PACS, or IDEXX’s practice management software is not whether the products are good — many of them are — but whether the referral decisions flowing through that system are genuinely clinical, or whether they have been structured by someone else’s architecture.

Most practices have never asked that question. IDEXX has built an empire on the assumption that they won’t.

The most powerful referral arrangement is the one no one recognizes as a referral arrangement at all.